Research ArticleNeuropharmacology
HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation
Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604
Xia-Yan Zhang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Xiao-Rong Wang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Dong-Min Xu
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Shu-Ying Yu
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Qiao-Juan Shi
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Li-Hui Zhang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Lu Chen
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
San-Hua Fang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Yun-Bi Lu
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Wei-Ping Zhang
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Er-Qing Wei
Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China (X.-Y.Z., X.-R.W., D.-M.X., S.-Y.Y., Q.-J.S., S.-H.F., Y.-B.L., W.-P.Z., E.-Q.W.); and Hangzhou Key Laboratory of Neurobiology and Department of Pharmacology, School of Basic Medicine, Hangzhou Normal University, Hangzhou, China (L.-H.Z., L.C.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
HAMI 3379 Attenuates Ischemia-Like Neuronal Injury
Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604
Research ArticleNeuropharmacology
HAMI 3379 Attenuates Ischemia-Like Neuronal Injury
Xia-Yan Zhang, Xiao-Rong Wang, Dong-Min Xu, Shu-Ying Yu, Qiao-Juan Shi, Li-Hui Zhang, Lu Chen, San-Hua Fang, Yun-Bi Lu, Wei-Ping Zhang and Er-Qing Wei
Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 328-341; DOI: https://doi.org/10.1124/jpet.113.203604
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement